Risk stratification of outcomes after coronary artery bypass grafting in ischemic cardiomyopathy with symptomatic

Shin Yajima1, Kazutaka Nishio2, Akinobu Ohtani3

  • 1Department of Cardiovascular Surgery, The University of Osaka Graduate School of Medicine, 2‑2 Yamadaoka, Suita, 565‑0871, Osaka, Japan. s-yajima@surg1.med.osaka-u.ac.jp.

Insights

Older age, high creatinine, and prior percutaneous coronary intervention predict worse outcomes in ischemic cardiomyopathy patients after coronary artery bypass grafting. Total revascularization improves survival.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Regenerative Medicine

Background:

  • Investigating predictors of mortality and heart failure events in patients with symptomatic ischemic cardiomyopathy (ICM).
  • Identifying stratification variables for future regenerative therapy trials in ICM patients undergoing coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To identify predictors of all-cause mortality and heart failure (HF) events in patients with ICM undergoing isolated CABG.
  • To explore potential stratification variables for future regenerative therapy trials.

Main Methods:

  • Retrospective analysis of 90 patients with ICM, ejection fraction ≤40%, and NYHA class ≥II undergoing primary isolated CABG.
  • Assessment of clinical characteristics, operative data, and long-term outcomes (all-cause mortality, HF events).
  • Prognostic factor evaluation using Kaplan-Meier analyses and multivariate Cox proportional hazard models.

Main Results:

  • Median follow-up of 45 months revealed 30.0% mortality, 15.6% HF readmissions, and 42.2% HF events.
  • Older age and high creatinine levels independently predicted mortality and HF events.
  • Prior percutaneous coronary intervention was linked to mortality; total revascularization showed a protective effect.

Conclusions:

  • Older age, elevated creatinine, and prior PCI are associated with poorer survival in symptomatic ICM patients post-CABG.
  • Total revascularization is linked to improved survival outcomes.
  • Findings suggest potential stratification variables for future regenerative therapy studies.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...